Amplia Therapeutics Limited to Present at the Life Sciences Virtual Investor Forum December 11th

About this update from Amplia Therapeutics Ltd.

[{"type":"image","alt":"Virtual Investor Conferences; Amplia Therapeutics","displaySize":"","headline":null,"caption":"Virtual Investor Conferences; Amplia Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":200,"url":"https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wFNFO9V7weOyJzKv3Grwwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI4MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc","width":300,"height":200}},"lazy":false},{"type":"text","content":"Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com","length":140,"tagName":"p"},{"type":"text","content":"MELBOURNE, Vic, Australia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (OTCQB:INNMF ASX:ATX), based in Melbourne, Australia and focused on developing new therapies for hard to treat cancers, today announced that Dr Chris Burns, CEO and Managing Director, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on December 11th.","length":395,"tagName":"p"},{"type":"text","content":"DATE: December 11th TIME: 3:00 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: December 11, 15 and 16, after 3pm ET. Schedule 1x1 Meetings here","length":150,"tagName":"p"},{"type":"text","content":"This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.","length":260,"tagName":"p"},{"type":"text","content":"It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.","length":137,"tagName":"p"},{"type":"text","content":"Learn more about the event at www.virtualinvestorconferences.com.","length":65,"tagName":"p"},{"type":"text","content":"Recent Company Highlights","length":25,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Top-line data from ACCENT pancreatic cancer trial indicates superior efficacy of narmafotinib dosed in combination with chemotherapy over chemotherapy alone","length":156,"tagName":"p"}]},{...

More updates from Amplia Therapeutics Ltd.